BIOMAT Database Logo BIOMAT Database Logo

Cefminox versus metronidazole plus gentamicin intra-abdominal infections: a prospective randomized controlled clinical trial. 2000

A J Torres, and L D Valladares, and J M Jover, and A Sánchez-Pernaute, and J Frías, and A J Carcas, and P Coronel, and E Ródenas, and I Pérez-Balcabao, and R Fernández-Roblas, and M Moreno, and J L Balibrea
Dept. of Surgery II, Clínico San Carlos Hospital, Complutense University, Madrid, Spain. AJTORRES@teleline.es

BACKGROUND The aim of this prospective study was to compare the safety and efficacy of a new cephamycin, cefminox 2 g/12 h, to those of the usual regimen combining metronidazole 500 mg/8 h and gentamicin 80 mg/8 h (M+G). METHODS 160 patients with clinically proven intra-abdominal infection were prospectively included in an open parallel randomized comparative multicenter trial. Antibiotics were started preoperatively and discontinued after clinical and laboratory evidence of resolution of the infection. Serum and peritoneal fluid levels and serum bactericidal activities were also studied. RESULTS 150 patients were clinically evaluable. There was one failure in the cefminox group and three in the M+G group (not significant, RR: 1.07, 95% CI: 1-1.15). No differences were found in the number of wound infections, length of stay or duration of antibiotic therapy. Adverse effects were reported in 11 cases, all of them mild to moderate. Escherichia coli and Bacteroides fragilis were the most frequently found microorganisms. CONCLUSIONS Cefminox is as effective and as safe as M+G in the treatment of intra-abdominal infections.

UI MeSH Term Description Entries
D008795 Metronidazole A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS. 2-Methyl-5-nitroimidazole-1-ethanol,Bayer 5360,Clont,Danizol,Flagyl,Gineflavir,Metric,MetroGel,Metrodzhil,Metrogyl,Metronidazole Hydrochloride,Metronidazole Monohydrochloride,Metronidazole Phosphate,Metronidazole Phosphoester,Satric,Trichazol,Trichopol,Trivazol,Vagilen,2 Methyl 5 nitroimidazole 1 ethanol
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002513 Cephamycins Naturally occurring family of beta-lactam cephalosporin-type antibiotics having a 7-methoxy group and possessing marked resistance to the action of beta-lactamases from gram-positive and gram-negative organisms. Antibiotics, Cephamycin,Cephamycin,Cephamycin Antibiotics
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D005839 Gentamicins A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS. Gentamicin Sulfate (USP),Gentamycin,G-Myticin,Garamycin,Gentacycol,Gentamicin,Gentamicin Sulfate,Gentamycins,Gentavet,Genticin,G Myticin,GMyticin,Sulfate, Gentamicin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000005 Abdomen That portion of the body that lies between the THORAX and the PELVIS. Abdomens
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

A J Torres, and L D Valladares, and J M Jover, and A Sánchez-Pernaute, and J Frías, and A J Carcas, and P Coronel, and E Ródenas, and I Pérez-Balcabao, and R Fernández-Roblas, and M Moreno, and J L Balibrea
A randomized multicentre trial of pefloxacin plus metronidazole and gentamicin plus metronidazole in the treatment of severe intra-abdominal infections. Report from a Swedish Study Group.
October 1990, The Journal of antimicrobial chemotherapy,
A J Torres, and L D Valladares, and J M Jover, and A Sánchez-Pernaute, and J Frías, and A J Carcas, and P Coronel, and E Ródenas, and I Pérez-Balcabao, and R Fernández-Roblas, and M Moreno, and J L Balibrea
Efficacy of tigecycline versus ceftriaxone plus metronidazole for the treatment of complicated intra-abdominal infections: results from a randomized, controlled trial.
April 2012, Surgical infections,
A J Torres, and L D Valladares, and J M Jover, and A Sánchez-Pernaute, and J Frías, and A J Carcas, and P Coronel, and E Ródenas, and I Pérez-Balcabao, and R Fernández-Roblas, and M Moreno, and J L Balibrea
Double-blind comparison of metronidazole plus gentamicin and clindamycin plus gentamicin in intra-abdominal infection.
January 1983, Surgery,
A J Torres, and L D Valladares, and J M Jover, and A Sánchez-Pernaute, and J Frías, and A J Carcas, and P Coronel, and E Ródenas, and I Pérez-Balcabao, and R Fernández-Roblas, and M Moreno, and J L Balibrea
A randomized prospective study of cefepime plus metronidazole with imipenem-cilastatin in the treatment of intra-abdominal infections.
June 2007, Infection,
A J Torres, and L D Valladares, and J M Jover, and A Sánchez-Pernaute, and J Frías, and A J Carcas, and P Coronel, and E Ródenas, and I Pérez-Balcabao, and R Fernández-Roblas, and M Moreno, and J L Balibrea
Meropenem monotherapy versus cefotaxime plus metronidazole combination treatment for serious intra-abdominal infections.
January 1996, Infection,
A J Torres, and L D Valladares, and J M Jover, and A Sánchez-Pernaute, and J Frías, and A J Carcas, and P Coronel, and E Ródenas, and I Pérez-Balcabao, and R Fernández-Roblas, and M Moreno, and J L Balibrea
Intravaginal metronidazole gel versus metronidazole plus nystatin ovules for bacterial vaginosis: a randomized controlled trial.
December 2004, American journal of obstetrics and gynecology,
A J Torres, and L D Valladares, and J M Jover, and A Sánchez-Pernaute, and J Frías, and A J Carcas, and P Coronel, and E Ródenas, and I Pérez-Balcabao, and R Fernández-Roblas, and M Moreno, and J L Balibrea
A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections. Cefepime Intra-abdominal Infection Study Group.
December 1997, Archives of surgery (Chicago, Ill. : 1960),
A J Torres, and L D Valladares, and J M Jover, and A Sánchez-Pernaute, and J Frías, and A J Carcas, and P Coronel, and E Ródenas, and I Pérez-Balcabao, and R Fernández-Roblas, and M Moreno, and J L Balibrea
Imipenem (N-F-thienamycin) versus netilmicin plus clindamycin. A controlled and randomized comparison in intra-abdominal infections.
March 1987, Annals of surgery,
A J Torres, and L D Valladares, and J M Jover, and A Sánchez-Pernaute, and J Frías, and A J Carcas, and P Coronel, and E Ródenas, and I Pérez-Balcabao, and R Fernández-Roblas, and M Moreno, and J L Balibrea
Cefoxitin versus gentamicin and metronidazole in prevention of post-appendicectomy sepsis: a randomized, prospective trial.
November 1986, The Journal of antimicrobial chemotherapy,
A J Torres, and L D Valladares, and J M Jover, and A Sánchez-Pernaute, and J Frías, and A J Carcas, and P Coronel, and E Ródenas, and I Pérez-Balcabao, and R Fernández-Roblas, and M Moreno, and J L Balibrea
Novel Beta-Lactam/Beta-Lactamase Plus Metronidazole vs Carbapenem for Complicated Intra-abdominal Infections: A Meta-analysis of Randomized Controlled Trials.
January 2021, Open forum infectious diseases,
Copied contents to your clipboard!